SCHEMBL7783161

SCHEMBL7783161

CCc1nc(NCCN)c2c3ccccc3n(-c3c(C)cc(C)cc3C)c2n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 3/20 0.54
IKBKB O14920 5/20 0.37
CHUK O15111 5/20 0.37
ERN1 O75460 1/20 0.37
RPS6KA4 O75676 1/20 0.37
PRKD3 O94806 1/20 0.37
CDK1 P06493 1/20 0.37
KIT P10721 1/20 0.37
CDK11B P21127 1/20 0.37
CDK2 P24941 1/20 0.37
TYK2 P29597 1/20 0.37
CSNK1D P48730 1/20 0.37
CDK7 P50613 1/20 0.37
CDK9 P50750 1/20 0.37
LIMK1 P53667 1/20 0.37
CDK16 Q00536 1/20 0.37
MAPK7 Q13164 1/20 0.37
CDK13 Q14004 1/20 0.37
PRKD1 Q15139 1/20 0.37
RPS6KA1 Q15418 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7788894 0.88 CRHR1 (0.62) CRHR1IKBKBCHUKERN1RPS6KA4
SCHEMBL7788181 0.84 CRHR1 (0.50) CRHR1IKBKBCHUKCDK11BCDK2
SCHEMBL7788907 0.84 CRHR1 (0.42) CRHR1KDM4ENPY1RPOLB
SCHEMBL7783147 0.81 CRHR1 (0.53) CRHR1PRKD2TP53KDM4ENPY1R
SCHEMBL7783159 0.78 CRHR1 (0.53) CRHR1
SCHEMBL7792967 0.74 CRHR1 (0.57) CRHR1PRKCHPRKCE
SCHEMBL7788887 0.74 CRHR1 (0.55) CRHR1TP53POLB
SCHEMBL7676276 0.73 CRHR1 (0.49) CRHR1TP53RXFP1
SCHEMBL7792997 0.73 CRHR1 (0.54) CRHR1IKBKBKDM4E
SCHEMBL7783154 0.73 CRHR1 (0.50) CRHR1TP53KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010031758-A1 Substituted 9H-pyridino[2,3-b] indole and 9H-pyrimidino[4,5-b] indole derivatives: selective neuropeptide Y receptor ligands NEUROGEN CORPORATION 2001-10-18 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010031758-A1 Substituted 9H-pyridino[2,3-b] indole and 9H-pyrimidino[4,5-b] indole derivatives: selective neuropeptide Y receptor ligands NPY1R, NPY2R, NPY5R CRHR1 33/4885IKBKB 1243/4885CHUK 753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.